Skip to main content
Mijn bibliotheek
Ga naar:
Nieuws Boeken Tijdschriften Toetsvragen Web-tv Video Audio
Tips voor Mijn BSL
BSL Shop
Inloggen

Welkom bij Erasmus MC & Bohn Stafleu van Loghum

Erasmus MC heeft ervoor gezorgd dat je Mijn BSL eenvoudig en snel kunt raadplegen. Je kunt je links eenvoudig registreren. Met deze gegevens kun je thuis, of waar ook ter wereld toegang krijgen tot Mijn BSL.

» Andere revante producten voor Erasmus MC studenten en medewerkers.

Registreer

Om ook buiten de locaties van Erasmus MC, thuis bijvoorbeeld, van Mijn BSL gebruik te kunnen maken, moet je jezelf eenmalig registreren. Dit kan alleen vanaf een computer op een van de locaties van Erasmus MC.

Eenmaal geregistreerd kun je thuis of waar ook ter wereld onbeperkt toegang krijgen tot Mijn BSL.

Login

Als u al geregistreerd bent, hoeft u alleen maar in te loggen om onbeperkt toegang te krijgen tot Mijn BSL.

Inloggen
Top
Journal of Autism and Developmental Disorders
Gepubliceerd in:

20-07-2021 | Letter to the Editor

Case Reports: Clozapine for the Treatment of Catatonia in Autism Spectrum Disorder

Auteurs: Robyn P. Thom, Christopher J. McDougle

Gepubliceerd in: Journal of Autism and Developmental Disorders | Uitgave 6/2022

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail
    Link delen
publish
Publiceer nu

Abstract

Catatonia is a severe clinical syndrome which has been increasingly reported in autism spectrum disorder (ASD). The prevalence of catatonia in ASD is unknown. Diagnosing catatonia in ASD is complicated by overlapping clinical features such as mutism, stereotypies, and echophenomena. Here, we present the clinical histories of two individuals with ASD and catatonia who were successfully treated with clozapine. We have reported on a novel potential treatment option for catatonia in ASD. Additional studies are needed to evaluate the safety, efficacy, and tolerability of clozapine for the treatment of catatonia in ASD.
vorige artikel Correction to: Concerns About ABA-Based Intervention: An Evaluation and Recommendations
Literatuur
Billstedt, E., Gillberg, C., & Gillberg, C. (2005). Autism after adolescence: Population-based 13- to 22-year follow-up study of 120 individuals with autism diagnosed in childhood. Journal of Autism and Developmental Disorders, 35(3), 351–360.CrossRef
Chattopadhyay, S., Saha, I., Dan, A., & Bhattacharyya, K. (2012). Clozapine responsive catatonia: A series of five cases. Industrial Psychiatry Journal, 21(1), 66.CrossRef
Collins, J., Halder, N., & Chaudhry, N. (2012). Use of ECT in patients with an intellectual disability: Review. The Psychiatrist, 36(2), 55–60.CrossRef
DeJong, H., Bunton, P., & Hare, D. J. (2014). A systematic review of interventions used to treat catatonic symptoms in people with autistic spectrum disorders. Journal of Autism and Developmental Disorders, 44(9), 2127–2136.CrossRef
Dhossche, D. M., Shah, A., & Wing, L. (2006). Blueprints for the assessment, treatment, and future study of catatonia in autism spectrum disorders. International Review of Neurobiology, 72, 267–284.CrossRef
Dhossche, D. M., & Stanfill, S. (2004). Could ECT be effective in autism? Med Hypotheses [internet], 63(3), 371–376.CrossRef
Ellul, P., Rotgé, J. Y., & Choucha, W. (2015). Resistant catatonia in a high-functioning autism spectrum disorder patient successfully treated with amantadine [Internet]. Journal of Child and Adolescent Psychopharmacology, 25(9), 726.CrossRef
England, M. L., Öngür, D., Konopaske, G. T., & Karmacharya, R. (2011). Catatonia in psychotic patients: Clinical features and treatment response. Journal of Neuropsychiatry and Clinical Neurosciences, 23(2), 223–226.CrossRef
Fink, M., Taylor, M. A., & Ghaziuddin, N. (2006). Catatonia in autistic spectrum disorders: A medical treatment algorithm. International Review of Neurobiology, 72, 233–244.CrossRef
Ghaziuddin, N., Dhossche, D., & Marcotte, K. (2012). Retrospective chart review of catatonia in child and adolescent psychiatric patients. Acta Psychiatrica Scand., 125(1), 33–38.CrossRef
Honigfeld, G., Arellano, F., Sethi, J., Bianchini, A., & Schein, J. (1998). Reducing clozapine-related morbidity and mortality: 5 years of experience with the Clozaril National Registry. Journal of Clinical Psychiatry, 59(SUPPL. 3), 3–7.PubMed
Horder, J., Petrinovic, M. M., Mendez, M. A., et al. (2018). Glutamate and GABA in autism spectrum disorder-a translational magnetic resonance spectroscopy study in man and rodent models. Translational Psychiatry, 8(1), 106.CrossRef
Jann, M. W. (1991). Clozapine. Pharmacother J Hum Pharmacol Drug Ther, 11(3), 179–195.
Lamberti, J. (2006). Prevalence of the metabolic syndrome among patients receiving clozapine. American Journal of Psychiatry, 163(7), 1273.CrossRef
Marrosu, F., Marrosu, G., Rachel, M. G., & Biggio, G. (1987). Paradoxical reactions elicited by diazepam in children with classic autism. Functional Neurology, 2(3), 355–361.PubMed
Meltzer, H. Y. (2012). Clozapine: Balancing safety with superior antipsychotic efficacy. Clinical Schizophrenia & Related Psychoses, 6(3), 134–144.CrossRef
Pelzer, A. C. M., van der Heijden, F. M. M. A., & den Boer, E. (2018). Systematic review of catatonia treatment. Neuropsychiatric Disease and Treatment, 14, 317–326.CrossRef
Rosebush, P. I., & Mazurek, M. F. (2010). Catatonia and its treatment. Schizophrenia Bulletin, 36(2), 239–242.CrossRef
Siskind, D., McCartney, L., Goldschlager, R., & Kisely, S. (2016). Clozapine v first- and second-generation antipsychotics in treatment-refractory schizophrenia: systematic review and meta-analysis. British Journal of Psychiatry, 209(5), 385–392.CrossRef
Wing, L., & Shah, A. (2000). Catatonia in autistic spectrum disorders. British Journal of Psychiatry, 176, 357–362.CrossRef
Wu, Y., Blichowski, M., Daskalakis, Z. J., et al. (2011). Evidence that clozapine directly interacts on the GABAB receptor. NeuroReport, 22(13), 637–641.CrossRef
Metagegevens
Titel
Case Reports: Clozapine for the Treatment of Catatonia in Autism Spectrum Disorder
Auteurs
Robyn P. Thom
Christopher J. McDougle
Publicatiedatum
20-07-2021
Uitgeverij
Springer US
Gepubliceerd in
Journal of Autism and Developmental Disorders / Uitgave 6/2022
Print ISSN: 0162-3257
Elektronisch ISSN: 1573-3432
DOI
https://doi.org/10.1007/s10803-021-05149-8

Andere artikelen Uitgave 6/2022

“I Spent Most of Freshers in my Room”—A Qualitative Study of the Social Experiences of University Students on the Autistic Spectrum

  • Open Access
  • Original Paper

Promoting Career Design in Youth and Young Adults with ASD: A Feasibility Study

  • Original Paper

The Impact of COVID-19 on Anxiety and Worries for Families of Individuals with Special Education Needs and Disabilities in the UK

  • Open Access
  • Original Paper

Concerns About ABA-Based Intervention: An Evaluation and Recommendations

  • Open Access
  • Commentary

Brief Report: The Influence of Autism Severity and Depression on Self-Determination Among Young Adults with Autism Spectrum Disorder

  • Brief Report

Brief Report: Sex/Gender Differences in Adolescents with Autism: Socialization Profiles and Response to Social Skills Intervention

  • Brief Report